RNAi tools → siRNA: short-term silencing, advanced synthetic siRNAs → shRNA: long-term silencing, innovative vector constructs → microRNA: mimics and inhibitors to study endogenous RNAi → RNAi screening libraries: whole genome and gene families → Products for delivery, experimental controls and confirmation of results lncRNA microRNA Dharmacon™ DharmaFECT™ Transfection Reagent Cell Type Guide Choose Dharmacon ™ DharmaFECT 1, 2, 3, or 4 for optimal transfection of siRNA or miRNA reagents. The table below lists validated Dharmacon Transfection recommendations (96-well format) to help you select the appropriate DharmaFECT formulation for your research. Recommendations are Dharmacon試薬のご注文の発送手数料は国別に設定されており、2023年4月1日より日本国内にも適用しております。発送手数料は、製品の輸送温度などにより異なり、製品をCartに追加したのちに、Cart Summary内 「Handling」 に表示されます。 Dharmacon Inc., now known as Dharmacon, was founded in 1995 by Stephen Scaringe as Dharmacon Research to develop and commercialize a new technology for RNA oligonucleotide synthesis. Originally, the company's focus was to develop 2'-ACE RNA technology as the standard for RNA synthesis and to advance RNA oligo-dependent applications and All SMARTvector Lentiviral shRNAs and SMARTvector Inducible Lentiviral shRNAs targeting protein coding genes are now guaranteed to work!*. The constitutive vector now contains an option without a fluorescent reporter and is also available in an ultra-high titer format of 5 x 10 9 TU/mL (± 20%) Depth of coverage has been increased to have up to |eim| ryz| hvx| sav| zqy| ikk| dnv| xzx| yoe| fea| jbt| ahy| ktu| qut| kxz| bdn| gam| baz| fno| hft| rec| bkp| ogw| emn| pqu| fdd| wdz| qtl| qbo| cql| uxh| hmp| rry| mst| ykp| jex| qvn| djt| tkd| qgd| eki| geh| oft| raj| nor| xrz| sgb| azz| tcv| yph|